Abstract
Our understanding of cancer pathways has been changed by the determination of noncoding transcripts in the human genome in recent years. miRNAs and pseudogenes are key players of the noncoding transcripts from the genome, and alteration of their expression levels provides clues for significant biomarkers in pathogenesis of diseases. Especially, miRNAs and pseudogenes have both oncogenic and tumor-suppressive roles in each step of cancer tumorigenesis. In this current study, association between oncogenes and miRNAs-pseudogenes was reviewed and determined in human cancer by the CellMiner web-tool.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Tutar L, Tutar E, Tutar Y (2014) MicroRNAs and cancer; an overview. Curr Pharm Biotechnol 15(5):430–437
Qu J, Li M, Zhong W, Hu C (2015) Competing endogenous RNA in cancer: a new pattern of gene expression regulation. Int J Clin Exp Med 8(10):17110–17116
Poliseno L, Marranci A, Pandolfi PP (2015) Pseudogenes in human cancer. Front Med 2:68
Garzon R, Calin GA, Croce CM (2009) MicroRNAs in cancer. Annu Rev Med 60:167–179
Schoof CRG, da Silva Botelho EL, Izzotti A, dos Reis Vasques L (2012) MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2(4):414–433
Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11(9):597–610
Tutar Y, Özgür A, Tutar E, Tutar L, Pulliero A et al (2016) Regulation of oncogenic genes by MicroRNAs and pseudogenes in human lung cancer. Biomed Pharmacother 83:1182–1190
Goodhead I, Darby AC (2015) Taking the pseudo out of pseudogenes. Curr Opin Microbiol 23:102–109
Tutar Y (2012) Pseudogenes. Comp Funct Genomics 2012:6–9
Korrodi-Gregório L, Abrantes J, Muller T, Melo-Ferreira J, Marcus K et al (2013) Not so pseudo: the evolutionary history of protein phosphatase 1 regulatory subunit 2 and related pseudogenes. BMC Evol Biol 13(1):242
Pink RC, Wicks K, Caley DP, Punch EK, Jacobs L et al (2011) Pseudogenes: pseudo-functional or key regulators in health and disease? RNA 17(5):792–798
Poliseno L (2012) Pseudogenes: newly discovered players in human cancer. Sci Signal 5(242):re5
Dweep H, Sticht C, Gretz N (2013) In-Silico algorithms for the screening of possible microRNA binding sites and their interactions. Curr Genomics 14(2):127–136
Shankavaram UT, Varma S, Kane D, Sunshine M, Chary KK et al (2009) CellMiner: a relational database and query tool for the NCI-60 cancer cell lines. BMC Genomics 10:277
Özgür A, Tutar L, Tutar Y (2014) Regulation of heat shock proteins by miRNAs in human breast cancer. Microrna 3(2):118–135
Baev V, Milev I, Naydenov M, Vachev T, Apostolova E et al (2014) Insight into small RNA abundance and expression in high- and low-temperature stress response using deep sequencing in Arabidopsis. Plant Physiol Biochem 84:105–114
Ribeiro AO, Schoof CRG, Izzotti A, Pereira LV, Vasques LR (2014) MicroRNAs: modulators of cell identity, and their applications in tissue engineering. Microrna 3(1):45–53
Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ et al (2010) A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465(7301):1033–1038
Chen C (2005) Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 33(20):e179
Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103(7):2257–2261
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834–838
Hui ABY, Shi W, Boutros PC, Miller N, Pintilie M et al (2009) Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Lab Invest 89(5):597–606
Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH et al (2010) The microRNA spectrum in 12 body fluids. Clin Chem 56(11):1733–1741
Gumireddy K, Young DD, Xiong X, Hogenesch JB, Huang Q et al (2008) Small-molecule inhibitors of microRNA miR-21 function. Angew Chem Int Ed Engl 47(39):7482–7484
Bader AG, Brown D, Winkler M (2010) The promise of microRNA replacement therapy. Cancer Res 70(18):7027–7030
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S et al (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99(24):15524–15529
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120(5):635–647
Yong SL, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21(9):1025–1030
Sampson VB, Rong NH, Han J, Yang Q, Aris V et al (2007) MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res 67(20):9762–9770
Muïler D, Bosserhoff A-K (2008) Integrin b 3 expression is regulated by let-7a miRNA in malignant melanoma. Oncogene 27282:6698–6706
Boyerinas B, Park SM, Shomron N, Hedegaard MM, Vinther J et al (2008) Identification of let-7-regulated oncofetal genes. Cancer Res 68(8):2587–2591
Forman JJ, Legesse-Miller A, Coller HA (2008) A search for conserved sequences in coding regions reveals that the let-7 microRNA targets dicer within its coding sequence. Proc Natl Acad Sci U S A 105(39):14879–14884
Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K et al (2008) Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 68(11):4123–4132
Michael MZ, O’Connor SM, van Holst Pellekaan NG, Young GP, James RJ (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1(12):882–891
Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G et al (2010) Reprogramming of miRNA networks in cancer and leukemia. Genome Res 20(5):589–599
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M et al (2005) A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353(17):1793–1801
Garzon R, Volinia S, Liu C, Fernandez-cymering C, Palumbo T et al (2008) MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 111(6):3183–3189
Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L et al (2008) Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 105(10):3945–3950
Ciafrè SA, Galardi S, Mangiola A, Ferracin M, Liu CG et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334(4):1351–1358
Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033
Meng F, Henson R, Wehbe–Janek H, Ghoshal K, Jacob ST et al (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133(2):647–658
Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A et al (2008) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283(2):1026–1033
Zhu S, Si ML, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282(19):14328–14336
Mendell JT (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133(2):217–222
O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435(7043):839–843
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65(16):7065–7070
Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A (2004) High expression of precursor MicroRNA-155/BIC RNA in children with Burkitt lymphoma. Genes Chromosomes Cancer 39(2):167–169
He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R et al (2005) The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 102(52):19075–19080
Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H et al (2004) Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64(11):3753–3756
Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K et al (2005) A polycistronic MicroRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65(21):9628–9632
Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H et al (2006) Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25:2537–2545
Tsai WC, Hsu PWC, Lai TC, Chau GY, Lin CW et al (2009) MicroRNA-122, a tumor suppressor MicroRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 49(5):1571–1582
Yoon SO, Chun SM, Han EH, Choi J, Jang SJ et al (2011) Deregulated expression of microRNA-221 with the potential for prognostic biomarkers in surgically resected hepatocellular carcinoma. Hum Pathol 42(10):1391–1400
Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A et al (2008) The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle 7(6):759–764
Trang P, Medina PP, Wiggins JF, Ruffino L, Kelnar K et al (2010) Regression of murine lung tumors by the let-7 microRNA. Oncogene 29(11):1580–1587
Seike M, Goto A, Okano T, Bowman ED, Schetter AJ et al (2009) MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 106(29):12085–12090
Yu F, Yao H, Zhu P, Zhang X, Pan Q et al (2007) Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131(6):1109–1123
Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P et al (2009) Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138(3):592–603
Si M-L, Zhu S, Wu H, Lu Z, Wu F et al (2007) miR-21-mediated tumor growth. Oncogene 26(19):2799–2803
Han HB, Gu J, Zuo HJ, Chen ZG, Zhao W et al (2012) Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer. J Pathol 226(3):544–555
Akao Y, Nakagawa Y, Naoe T (2006) Let-7 MicroRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29(5):903–906
Wang F, Zhang P, Maa Y, Yang J, Moyer MP et al (2012) NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA. Cancer Lett 314(2):223–231
Chen Y, Ma C, Zhang W, Chen Z, Ma L (2014) Down regulation of miR-143 is related with tumor size, lymph node metastasis and HPV16 infection in cervical squamous cancer. Diagn Pathol 9:88
Link A, Balaguer F, Shen Y, Nagasaka T, Lozano JJ et al (2010) Fecal microRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 19(7):1766–1774
Medina PP, Nolde M, Slack FJ (2010) OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467(7311):86–90
Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K et al (2010) Genome-wide RNA-mediated interference screen identifies miR-19 targets in notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 12(4):372–379
Chaudhuri AA, So AY-L, Mehta A, Minisandram A, Sinha N et al (2012) Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. Proc Natl Acad Sci U S A 109(11):4233–4238
Han J, Li A, Liu H, Wen X, Zhao M et al (2014) Computational identification of microRNAs in the strawberry (Fragaria x Ananassa) genome sequence and validation of their precise sequences by miR-RACE. Gene 536(1):151–162
Wang M, Tan L, Dijkstra M, van Lom K, Robertus J-L et al (2008) miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-150 and high BIC/miR-155 expression. J Pathol 215(1):13–20
Kalyana-Sundaram S, Kumar-Sinha C, Shankar S, Robinson DR, Wu YM et al (2012) Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 149(7):1622–1634
Welch JD, Baran-Gale J, Perou CM, Sethupathy P, Prins JF (2015) Pseudogenes transcribed in breast invasive carcinoma show subtype-specific expression and ceRNA potential. BMC Genomics 16(1):113
Han L, Yuan Y, Zheng S, Yang Y, Li J et al (2014) The pan-cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes. Nat Commun 5:3963
Conflict of Interest
The authors confirm that this article content has no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Tutar, L., Özgür, A., Tutar, Y. (2018). Involvement of miRNAs and Pseudogenes in Cancer. In: Wu, W. (eds) MicroRNA and Cancer. Methods in Molecular Biology, vol 1699. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7435-1_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7435-1_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7433-7
Online ISBN: 978-1-4939-7435-1
eBook Packages: Springer Protocols